✦ LIBER ✦

CN8 AN ECONOMIC EVALUATION OF DASATINIB (SPRYCEL®) IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN CENTRAL AND EASTERN EUROPE

✍ Scribed by B Nagy; L Kutikova; M Stastny; K Vasile; I Zsolnai Nagy; J Mayer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EC2 AN ECONOMIC EVALUATION OF DASATINIB

✍ MJ Taylor; K Minda; KH Cerri; C Davis; HJ Kan; S Ray 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PCN124 COST-UTILITY ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PCN14 THE COST AND COST EFFECTIVENESS OF

✍ Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Lital 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Efficacy and safety of dasatinib versus

✍ Fujisawa, Shin; Nakamae, Hirohisa; Ogura, Michinori; Ishizawa, Ken-ichi; Taniwak 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 367 KB